Welcome to HealthyDogPetCo Blog

Sitemap xml

Free PMC article. No abstract available.

. Aminian A, et al. Diabetes Care. 2021 Sep 9:dc203023. doi: 10.2337/dc20-3023. Online ahead of print. Diabetes Care. 2021. PMID: 34503954 .
Programmable RNA targeting with the single-protein CRISPR effector Cas7-11.
Özcan A, Krajeski R, Ioannidi E, Lee B, Gardner A, Makarova KS, Koonin EV, Abudayyeh OO, Gootenberg JS. .
The immunostimulatory RNA RN7SL1 enables CAR-T cells to enhance autonomous and endogenous immune function.
Johnson LR, Lee DY, Eacret JS, Ye D, June CH, Minn AJ. Johnson LR, et al. .
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial.
Marconi VC, Ramanan AV, de Bono S, Kartman CE, Krishnan V, Liao R, Piruzeli MLB, Goldman JD, Alatorre-Alexander J, de Cassia Pellegrini R, Estrada V, Som M, Cardoso A, Chakladar S, Crowe B, Reis P, Zhang X, Adams DH, Ely EW; COV-BARRIER Study Group. .
Persistent mRNA localization defects and cell death in ALS neurons caused by transient cellular stress.
Markmiller S, Sathe S, Server KL, Nguyen TB, Fulzele A, Cody N, Javaherian A, Broski S, Finkbeiner S, Bennett EJ, Lécuyer E, Yeo GW.

top
top
Page
Menu
News
Home Print viewSitemap